NovaBay Pharmaceuticals Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $3.04M Miss $3.51M Estimate
NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is unchanged from the same period last year. The company